In the present study, the serum FAS levels of the gastric cancer patients were found to be significantly higher in comparison to the healthy controls, indicating that high concentrations of FAS in serum may result from enzyme secretion by cancer cells. The gene discussed is FAS; the disease is gastric cancer.